News

Paul Cauthen is making it clear that he is determined not to slow down or back down as he battles cancer. The country music singer shared a handful of Instagram stories across the past week that ...
Ian Smith, known as Harold Bishop in 'Neighbours', diagnosed with rare lung cancer: pulmonary pleomorphic carcinoma. Describes his diagnosis as a 'cruel, ugly, brutal place' with a feeling of ...
People with the hereditary disease familial adenomatous polyposis (FAP) have a greatly increased risk of developing a malignant tumor of the duodenum. Researchers have now discovered a mechanism in ...
Researchers with City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U ...
Podium presentation showcases the clinical application of Preciseâ„¢ MRDSALT LAKE CITY, April 25, 2025 (GLOBE NEWSWIRE) -- ...
Summit Therapeutics stock tumbled 37% on Friday afternoon after the U.S. Food and Drug Administration (FDA) approved its ...
Akeso Inc. scored U.S. FDA approval of the PD-1 monoclonal antibody penpulimab in combination with cisplatin or carboplatin and gemcitabine for the first-line treatment of adult recurrent or ...
Agenus Inc. (Nasdaq: AGEN), a clinical-stage immuno-oncology company, today announced updated data from the hepatocellular carcinoma (HCC) cohort of its ongoing Phase 1 study evaluating botensilimab ...
Summit Therapeutics (SMMT) stock plunges 35% a day after the FDA approval of partner Akeso's (AKESF) cancer drug, ...
Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck ...
Approval of penpulimab-kcqx marks the company’s US regulatory debut and introduces a new immunotherapy option for advanced ...
Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal ...